CIK 0001022899 · Non-accelerated filer<br>Smaller reporting company
Protagenic Therapeutics, Inc.new
Sign in to watch- Ticker
- PTIX
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061390025
- Phone
- (212) 994-8200
- Business address
- 149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
- Former names
- Atrinsic, Inc., NEW MOTION, INC., MPLC, Inc., MILLBROOK PRESS INC
- Open-market buys, last 90 days
- $23,756
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$23,756. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2010-01-27 | SCHWARTZ JEFFREY A Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2010-01-27 | SCHWARTZ JEFFREY A Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2010-01-20 | CHAZEN JEROME A Director | Other acquisition | +41,049 | 53,234 | ||
| 2010-01-06 | Trinad Capital Master Fund Ltd. 10% owner | Other disposition | −1,323,467 | 1,792,695 | ||
| 2009-12-21 | Trinad Capital Master Fund Ltd. 10% owner | Purchase | +5,376 | $0.60 | $3K | 3,116,262 |
| 2009-12-14 | Trinad Capital Master Fund Ltd. 10% owner | Purchase | +527,683 | $0.65 | $343K | 3,110,886 |
| 2009-12-09 | Trinad Capital Master Fund Ltd. 10% owner | Purchase | +21,947 | $0.67 | $15K | 2,583,203 |
| 2009-12-08 | Trinad Capital Master Fund Ltd. 10% owner | Purchase | +86,386 | $0.66 | $57K | 2,561,256 |
| 2009-11-19 | Trinad Capital Master Fund Ltd. 10% owner | Purchase | +25,000 | $0.85 | $21K | 2,474,870 |
| 2009-11-16 | Trinad Capital Master Fund Ltd. 10% owner | Purchase | +50,500 | $0.85 | $43K | 2,449,870 |
| 2009-11-13 | Trinad Capital Master Fund Ltd. 10% owner | Purchase | +50,000 | $0.86 | $43K | 2,399,370 |
| 2009-11-12 | Trinad Capital Master Fund Ltd. 10% owner | Purchase | +11,100 | $0.85 | $9K | 2,349,370 |
| 2009-09-17 | DYNE MARK Director | Grant or award | +40,000 | 766,369 | ||
| 2009-06-25 | STOLLMAN ANDREW President | Returned to the company · Stock Option (Right to Buy) | −300,000 | 0 | ||
| 2009-06-25 | STOLLMAN ANDREW President | Grant or award · Restricted Stock Units | +100,000 | 100,000 | ||
| 2009-06-25 | STOLLMAN ANDREW President | Grant or award · Restricted Stock Units | +275,000 | 275,000 | ||
| 2009-06-25 | CHAZEN JEROME A Director | Grant or award | +11,392 | 12,185 | ||
| 2009-06-25 | SCHWARTZ JEFFREY A Director | Grant or award | +3,892 | 3,892 | ||
| 2009-06-25 | ZAREF ANDREW Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −200,000 | 0 | ||
| 2009-06-25 | ZAREF ANDREW Chief Financial Officer | Grant or award · Restricted Stock Units | +66,667 | 66,667 |
Page 6 of 10 · 196 trades